This invention relates to a medicament containing as an active ingredient, a
novel propanolamine having a 1,4-benzodioxane ring or a pharmaceutically acceptable
salt thereof:
##STR1##
The present compound is represented by the above formula wherein R1-3
may be the same or different and each represents a hydrogen atom, a halogen atom,
a hydroxy group, a (C1-C6)alkyl group, a (C1-C6)alkoxy
group, a (C1-C6)alkylsulfonamido group, or a phenyl group;
R4-5 each represents a hydrogen atom or a (C1-C6)alkyl
group; and A represents any of a benzene ring, a pyridine ring and a pyrimidine ring.
This compound is useful as a prophylactic or therapeutic agent for diabetes,
obesity, hyperlipemia, depression, a respiratory disease, or a gastrointestinal disease.
